GI-overlap, low structural suspicion
Start with Modules 1, 2, and 5 when bloating, constipation, diarrhoea, food-linked symptoms, and cyclical worsening are present but the immediate question is overlap management.
InsideHer Learning
A clinician-facing course on cyclical GI and urinary symptoms, overlap phenotypes, imaging and referral logic, deep disease pathways, and patient counseling.
Return to All Endometriosis CoursesCourse Overview
This course is for clinicians who need a practical frame for differentiating overlap symptoms from suspected deep disease, avoiding diagnostic minimization, and matching the patient to the right imaging, service, and management path.
At A Glance
Quick Start
This course works best when it helps sort the consult by dominant pattern rather than treating all bowel or urinary symptoms as either incidental or automatically surgical.
Start with Modules 1, 2, and 5 when bloating, constipation, diarrhoea, food-linked symptoms, and cyclical worsening are present but the immediate question is overlap management.
Start with Modules 1, 3, and 4 when painful bowel motions, rectal pain, cyclical rectosigmoid-type symptoms, or prior imaging raise concern for deep disease.
Start with Modules 1, 3, and 5 when pain passing urine, urgency, cyclical urinary symptoms, or haematuria with menses raise concern for bladder or ureter involvement.
Start with Modules 4 and 6 when empirical treatment has not restored function and the next decision is repeat medical management versus imaging, referral, or specialist review.
Clinical Shortcut
The key clinical move is not to decide instantly whether the symptom is “GI,” “bladder,” or “endo.” It is to decide whether the pattern justifies empirical support alone or a deeper imaging and referral pathway.
Module 1
NICE explicitly includes cyclical GI symptoms, painful bowel movements, cyclical urinary symptoms, and haematuria as features that should raise suspicion for endometriosis. The first task is to make the pattern visible rather than fragmented across specialties.
Painful bowel motions, rectal pressure, cyclical bowel pain, and recurrent GI flares tightly linked to menses or pelvic pain history.
Dysuria, urgency, bladder pain, or visible blood in urine around periods, especially when recurrent and not explained coherently elsewhere.
Broad bowel or bladder symptoms that coexist with pelvic floor pain, IBS-type triggers, generalized chronic pelvic pain, or non-cyclical amplification.
Module 2
Bowel and urinary symptoms in endometriosis rarely belong to one clean bucket. Overlap with IBS, bladder pain syndrome, pelvic floor dysfunction, and persistent pain phenotypes is common.
Food-linked symptoms, bloating, urgency, constipation, and diarrhoea may warrant GI-style support even when the broader history remains suspicious for endometriosis.
Urinary urgency and suprapubic pain may coexist with endometriosis or reflect a non-endo bladder pain syndrome that still needs recognition and management.
Persistent guarding, dyspareunia, and amplified pain responses can intensify bowel or urinary symptoms even when structural disease is present.
Guardrail
Overlap management is useful, but it should not become a default reason to postpone imaging, referral, or specialist review when the symptom pattern remains strongly suggestive.
Module 3
NICE now recommends transvaginal ultrasound for all suspected endometriosis patients, including to identify deep disease involving bowel, bladder, or ureter, alongside parallel referral and initial pharmacological management when needed.
Use ultrasound not only to detect endometrioma or deep disease, but to support referral to the right service depending on findings and clinical suspicion.
NICE states endometriosis should not be excluded solely because examination and ultrasound are normal, and referral may still be required.
Suspected or confirmed deep disease involving bowel, bladder, or ureter should move into specialist endometriosis service framing rather than repeated generic follow-up.
Module 4
Medical therapy may still be appropriate for pain suppression, but bowel and bladder phenotypes often require clearer expectations about what hormones can and cannot do, and when surgery becomes a more coherent discussion.
Analgesia and hormonal suppression may reduce cyclical pain, but incomplete GI or urinary response should not be surprising when overlap or deeper disease is driving symptoms.
ESHRE notes surgery for deep endometriosis may improve pain and quality of life in selected patients, but specialist counseling on risks, benefits, and longer-term outcomes is essential.
A postoperative plan still matters, including symptom review, overlap management, and considering hormone treatment when immediate pregnancy is not desired.
Guardrail
Management quality depends on keeping both truths visible: overlap is common, and deep bowel or urinary involvement still warrants timely recognition and specialist care.
Module 5
Patients with bowel and urinary symptoms are often exhausted by fragmented explanations. The most useful counseling helps them understand the pattern without asking them to self-diagnose.
Module 6
Bowel and urinary symptom pathways work better when the follow-up logic is visible: what will count as adequate response, and what will trigger escalation.
Printable Shortcut
Open the Clinician Endometriosis Treatment Decision Aid for general treatment sequencing, then pair it with the Bowel and Bladder Symptom Guide when the consult is specifically bowel or urinary dominated.